» Articles » PMID: 28954412

Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and Nonalcoholic Steatohepatitis-Related Liver Disease

Overview
Journal Diseases
Date 2017 Sep 29
PMID 28954412
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We aim to study the impact of the baby boomer (BB) generation, a birth-specific cohort (born 1945-1965) on hepatocellular carcinoma (HCC)-related liver transplantation (LT) in patients with chronic hepatitis C virus (HCV), alcoholic liver disease (ALD), and non-alcoholic steatohepatitis (NASH). We performed a retrospective analysis using the United Network for Organ Sharing (UNOS)/Organ Procurement Transplant Network (OPTN) database from 2003 to 2014 to compare HCC-related liver transplant surgery trends between two cohorts-the BB and non-BB-with a secondary diagnosis of HCV, ALD, or NASH. From 2003-2014, there were a total of 8313 liver transplant recipients for the indication of HCC secondary to HCV, ALD, or NASH. Of the total, 6658 (80.1%) HCC-related liver transplant recipients were BB. The number of liver transplant surgeries for the indication of HCC increased significantly in NASH (+1327%), HCV (+382%), and ALD (+286%) during the study period. The proportion of BB who underwent LT for HCC was the highest in HCV (84.7%), followed by NASH (70.3%) and ALD (64.7%). The recommendations for birth-cohort specific HCV screening stemmed from a greater understanding of the high prevalence of chronic HCV and HCV-related HCC within BB. The rising number of HCC-related LT among BB with ALD and NASH suggests the need for increased awareness and improved preventative screening/surveillance measures within NASH and ALD cohorts as well.

Citing Articles

Resource Management through Artificial Intelligence in Screening Programs-Key for the Successful Elimination of Hepatitis C.

Butaru A, Mamuleanu M, Streba C, Doica I, Diculescu M, Gheonea D Diagnostics (Basel). 2022; 12(2).

PMID: 35204437 PMC: 8871056. DOI: 10.3390/diagnostics12020346.


Hepatitis C Antibody Screening Among Baby Boomers by a Community-Based Health Insurance Company.

Litaker J, Tamez N, Lopez Bray C, Allison R, Durkalski W, Taylor R Popul Health Manag. 2020; 24(4):492-495.

PMID: 33197366 PMC: 8403194. DOI: 10.1089/pop.2020.0214.


Advanced Hepatocellular Carcinoma Tumor Stage at Diagnosis in the 1945-1965 Birth Cohort Reflects Poor Use of Hepatocellular Carcinoma Screening.

Robinson A, Tavakoli H, Liu B, Bhuket T, Wong R Hepatol Commun. 2018; 2(9):1147-1155.

PMID: 30202827 PMC: 6128228. DOI: 10.1002/hep4.1236.

References
1.
Biggins S, Bambha K, Terrault N, Inadomi J, Shiboski S, Dodge J . Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma. Liver Transpl. 2012; 18(12):1471-8. PMC: 3518670. DOI: 10.1002/lt.23551. View

2.
Northup P, Intagliata N, Shah N, Pelletier S, Berg C, Argo C . Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation. Hepatology. 2014; 61(1):285-91. DOI: 10.1002/hep.27283. View

3.
Altekruse S, McGlynn K, Reichman M . Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009; 27(9):1485-91. PMC: 2668555. DOI: 10.1200/JCO.2008.20.7753. View

4.
Fattovich G, Stroffolini T, Zagni I, Donato F . Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004; 127(5 Suppl 1):S35-50. DOI: 10.1053/j.gastro.2004.09.014. View

5.
Wong R, Cheung R, Ahmed A . Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology. 2013; 59(6):2188-95. DOI: 10.1002/hep.26986. View